Skip header and navigation

Refine By

38 records – page 1 of 4.

[Active and passive smoking among personnel at the Bispebjerg Hospital 1992-1999]

https://arctichealth.org/en/permalink/ahliterature67455
Source
Ugeskr Laeger. 2000 Oct 16;162(42):5623-7
Publication Type
Article
Date
Oct-16-2000
Author
A D Olsen
A M Fugleholm
S. Rasmussen
V. Backer
S J Jørgensen
H. Tønnesen
L. Iversen
Author Affiliation
H:S Bispebjerg Hospital, lungemedicinsk enhed.
Source
Ugeskr Laeger. 2000 Oct 16;162(42):5623-7
Date
Oct-16-2000
Language
Danish
Publication Type
Article
Keywords
Attitude to Health
Cross-Sectional Studies
Denmark - epidemiology
English Abstract
Female
Humans
Male
Personnel, Hospital - psychology
Questionnaires
Smoking - epidemiology - psychology
Socioeconomic Factors
Tobacco Smoke Pollution - statistics & numerical data
Abstract
The purpose of this study was to describe changes in smoking behaviour and exposure to passive smoking among hospital employees at a large Danish University Hospital (Bispebjerg Hospital) from 1992 until 1999 as part of a program toward a smoke-free hospital. The study was based upon three cross-sectional self-administered questionnaires surveys carried out among all employees at the hospital--approximately 4000 persons--in October 1992, April 1997 and April 1999, participation rates being 84, 80 and 76 percent. During the seven year period the smoking rate has decreased from 46% to 32% among male and 40% to 33% among female employees. A decrease in smoking rate was found among all subgroups of employees. Among male employees the rate of heavy smokers has decreased from 25 to 16%, among female employees this decrease is lacking, the rate of heavy smokers being 15% during the whole period. The numbers of employees exposed to passive smoking all day or most of the day has changed from 39% to 25% from 1992 until 1999. Among the smokers 30%--8% of all employees--responded that they would not be able to manage without smoking tobacco during working hours. This answer is most commonly found among heavy smokers, smokers with short or no education and smokers who smoke at any time of day. It is concluded that even though there has been a reduction in the smoking rate, the exposure to passive smoking among employees at the hospital still is unacceptably high. Based upon these results it has been decided that Bispebjerg Hospital is smoke-free for all employees from the 1st of January 2000. There is a need for initiatives for the smokers, who can't manage work without smoking.
PubMed ID
11059300 View in PubMed
Less detail

Alcohol consumption among laid-off workers before and after closure of a Danish ship-yard: a 2-year follow-up study.

https://arctichealth.org/en/permalink/ahliterature12684
Source
Soc Sci Med. 1986;22(1):107-9
Publication Type
Article
Date
1986
Author
L. Iversen
H. Klausen
Source
Soc Sci Med. 1986;22(1):107-9
Date
1986
Language
English
Publication Type
Article
Keywords
Alcohol Drinking
Alcoholism - etiology
Denmark
Follow-Up Studies
Humans
Male
Middle Aged
Research Support, Non-U.S. Gov't
Risk
Ships
Unemployment
Abstract
The daily consumption of alcohol in a study of a population of Danish ship-yard workers laid off in relation to unexpected closure, was measured in 1976 (7 months before being laid off) and in 1978 (1 1/2 year after being laid off). The study population (N = 88) consisted mostly of skilled male workers. Data in 1976 and 1978 were collected in exactly the same manner. The main findings were that the unemployed workers were more likely to reduce their alcohol consumption than the reemployed workers in the same population-controlling for age. The study brings no evidence which could support the popular belief of a causal relation between unemployed and use of alcohol.
PubMed ID
3952525 View in PubMed
Less detail

[Alcohol consumption among young people]

https://arctichealth.org/en/permalink/ahliterature10609
Source
Ugeskr Laeger. 1999 Jun 14;161(24):3641-4
Publication Type
Article
Date
Jun-14-1999
Author
E P Due
K. Broholm
B E Holstein
L. Iversen
Author Affiliation
Københavns Universitet, Afdeling for Social Medicin og Psykosocial Sundhed.
Source
Ugeskr Laeger. 1999 Jun 14;161(24):3641-4
Date
Jun-14-1999
Language
Danish
Publication Type
Article
Keywords
Adolescent
Alcohol Drinking - epidemiology - prevention & control - trends
Child
Denmark - epidemiology
Female
Humans
Male
PubMed ID
10485219 View in PubMed
Less detail

[A neglected field: oral hygiene in nursing homes and homes for the aged. Interview by Henry Harm.]

https://arctichealth.org/en/permalink/ahliterature75884
Source
Sykepleien. 1981 May 5;68(8):12-3, 15
Publication Type
Article
Date
May-5-1981
Author
S L Iversen
Source
Sykepleien. 1981 May 5;68(8):12-3, 15
Date
May-5-1981
Language
Norwegian
Publication Type
Article
Keywords
Aged
Homes for the Aged
Humans
Norway
Nursing Homes
Oral Hygiene
PubMed ID
6912709 View in PubMed
Less detail

Application of mussels as biosamplers for characterization of faecal pollution in coastal recreational waters.

https://arctichealth.org/en/permalink/ahliterature141583
Source
Water Sci Technol. 2010;62(3):586-93
Publication Type
Article
Date
2010
Author
P. Roslev
A S Bukh
L. Iversen
H. Sønderbo
N. Iversen
Author Affiliation
Department of Biotechnology, Chemistry and Environmental Engineering, Aalborg University, Sohngaardsholmsvej 57, Aalborg DK-9000, Denmark. pr@bio.aau.dk
Source
Water Sci Technol. 2010;62(3):586-93
Date
2010
Language
English
Publication Type
Article
Keywords
Agriculture
Animals
Bivalvia - microbiology
Denmark
Environmental Monitoring - methods
Escherichia coli - genetics - isolation & purification
Genetic markers
Humans
Phylogeny
Recreation
Sewage
Time Factors
Water Microbiology - standards
Water Pollutants - analysis
Water Pollution - prevention & control
Abstract
Sources of faecal pollution in coastal recreational waters may be identified by analysing different host associated microorganisms or molecular markers. However, the microbial targets are often present at low numbers in moderately impacted waters, and often exhibit significant temporal and spatial variability in waters with fluctuating faecal loads. This patchy occurrence can limit successful detection of relevant targets in microbial source tracking studies. In this study, we explored the possibility for using the blue mussel (Mytilus edulis) as a biosampler for accumulation of faecal bacteria relevant for microbial source tracking. Non-contaminated blue mussels were transferred to three coastal recreational waters affected by faecal pollution of unknown origin. Molecular markers associated with animal and human waste were targeted by PCR and compared in seawater and mussel samples. The results demonstrated that transplanted mussels in simple enclosures accumulated and retained elevated levels of molecular markers associated with different types of faecal pollution. The targets included a novel putative human associated E. coli subgroup B2 VIII clone, and animal and human associated markers in enterococci (esp, M19, M66, M90, and M91). Human (sewage) associated markers including esp and M66 were sometimes not detectable in seawater samples despite known wastewater contamination, whereas the markers were detectable in mussels. We suggest that transplanted mussels should be considered as potential biosamplers in studies focusing on identifying source of faecal pollution in low or moderately impacted recreational waters. Bioaccumulation of molecular markers in mussels for several days may represent the water quality better than traditional grab samples from the water column.
PubMed ID
20706005 View in PubMed
Less detail

[Awareness and behavior in relation to occupational evironment].

https://arctichealth.org/en/permalink/ahliterature248601
Source
Ugeskr Laeger. 1978 May 8;140(19):1123-32
Publication Type
Article
Date
May-8-1978
Author
H. Klausen
L. Iversen
A. Grunnet
Source
Ugeskr Laeger. 1978 May 8;140(19):1123-32
Date
May-8-1978
Language
Danish
Publication Type
Article
Keywords
Awareness
Behavior
Cognition
Denmark
Environment
Humans
Middle Aged
Occupational Medicine
Ships
PubMed ID
653866 View in PubMed
Less detail

Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study.

https://arctichealth.org/en/permalink/ahliterature120848
Source
J Intern Med. 2013 Feb;273(2):197-204
Publication Type
Article
Date
Feb-2013
Author
O. Ahlehoff
L. Skov
G. Gislason
J. Lindhardsen
S L Kristensen
L. Iversen
S. Lasthein
R. Gniadecki
T N Dam
C. Torp-Pedersen
P R Hansen
Author Affiliation
Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark. olahha01@geh.regionh.dk
Source
J Intern Med. 2013 Feb;273(2):197-204
Date
Feb-2013
Language
English
Publication Type
Article
Keywords
Anti-Inflammatory Agents - therapeutic use
Cardiovascular Diseases - chemically induced - prevention & control
Cohort Studies
Confidence Intervals
Denmark
Dermatologic Agents - therapeutic use
Female
Humans
Longitudinal Studies
Male
Methotrexate - therapeutic use
Middle Aged
Psoriasis - drug therapy
Retrospective Studies
Risk factors
Severity of Illness Index
Abstract
Psoriasis is a chronic inflammatory disorder associated with cardiovascular morbidity and mortality. Systemic anti-inflammatory drugs, including biological agents, are widely used in the treatment of patients with moderate to severe psoriasis and may attenuate the risk of cardiovascular disease events. We therefore examined the rate of cardiovascular disease events in patients with severe psoriasis treated with systemic anti-inflammatory drugs.
Individual-level linkage of nationwide administrative databases was used to assess the event rates associated with use of biological agents, methotrexate or other therapies, including retinoids, cyclosporine and phototherapy, in Denmark from 2007 to 2009.
Death, myocardial infarction and stroke.
A total of 2400 patients with severe psoriasis, including 693 patients treated with biological agents and 799 treated with methotrexate, were identified. Incidence rates per 1000 patient-years and 95% confidence intervals (CIs) for the composite endpoint were 6.0 (95% CI 2.7-13.4), 17.3 (95% CI 12.3-24.3) and 44.5 (95% CI 34.6-57.0) for patients treated with biological agents, methotrexate and other therapies, respectively. Age- and sex-adjusted hazard ratios (HRs) were 0.28 (95% CI 0.12-0.64) and 0.65 (95% CI 0.42-1.00) for patients treated with biological agents and methotrexate, respectively, using other therapies as the reference cohort. Corresponding HRs for a secondary composite endpoint of cardiovascular death, myocardial infarction and stroke were 0.48 (95% CI 0.17-1.38) and 0.50 (95% CI 0.26-0.97).
In this nationwide study of patients with severe psoriasis, systemic anti-inflammatory treatment with biological agents or methotrexate was associated with lower cardiovascular disease event rates compared to patients treated with other anti-psoriatic therapies.
Notes
Comment In: J Intern Med. 2013 Sep;274(3):288-923600496
PubMed ID
22963528 View in PubMed
Less detail

Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort.

https://arctichealth.org/en/permalink/ahliterature271213
Source
J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1128-34
Publication Type
Article
Date
Jun-2015
Author
O. Ahlehoff
L. Skov
G. Gislason
R. Gniadecki
L. Iversen
L E Bryld
S. Lasthein
J. Lindhardsen
S L Kristensen
C. Torp-Pedersen
P R Hansen
Source
J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1128-34
Date
Jun-2015
Language
English
Publication Type
Article
Keywords
Adult
Aged
Anti-Inflammatory Agents - therapeutic use
Biological Products - therapeutic use
Cardiovascular Diseases - mortality
Cause of Death
Climatotherapy
Cyclosporine - therapeutic use
Denmark - epidemiology
Dermatologic Agents - therapeutic use
Female
Follow-Up Studies
Humans
Incidence
Longitudinal Studies
Male
Methotrexate - therapeutic use
Middle Aged
Myocardial Infarction - epidemiology
Phototherapy
Psoriasis - drug therapy - therapy
Registries
Retinoids - therapeutic use
Severity of Illness Index
Stroke - epidemiology
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Ustekinumab - therapeutic use
Abstract
Psoriasis is a common disease and is associated with cardiovascular diseases. Systemic anti-inflammatory drugs may reduce risk of cardiovascular events. We therefore examined the rate of cardiovascular events, i.e. cardiovascular death, myocardial infarction and stroke, in patients with severe psoriasis treated with systemic anti-inflammatory drugs.
Individual-level linkage of administrative registries was used to perform a longitudinal nationwide cohort study. Time-dependent multivariable adjusted Cox regression was used to estimate hazard ratios (HRs) with 95% confidence intervals (CIs) of cardiovascular events associated with use of biological drugs, methotrexate, cyclosporine, retinoids and other antipsoriatic therapies, including topical treatments, phototherapy and climate therapy.
A total of 6902 patients (9662 treatment exposures) with a maximum follow-up of 5 years were included. Incidence rates per 1000 patients-years for cardiovascular events were 4.16, 6.28, 6.08, 18.95 and 14.63 for biological drugs, methotrexate, cyclosporine, retinoid and other therapies respectively. Relative to other therapies, methotrexate (HR 0.53; CI 0.34-0.83) was associated with reduced risk of the composite endpoint and a comparable but non-significant protective effect was observed with biological drugs (HR 0.58; CI 0.30-1.10), whereas no protective effect was apparent with cyclosporine (HR 1.06; CI 0.26-4.27) and retinoids (HR 1.80; CI 1.03-2.96). Tumour necrosis factor inhibitors (HR 0.46; CI 0.22-0.98) were linked to reduced event rates, whereas the interleukin-12/23 inhibitor ustekinumab (HR 1.52; CI 0.47-4.94) was not.
Systemic anti-inflammatory treatment with methotrexate was associated with significantly lower rates of cardiovascular events during long-term follow-up compared to patients treated with other antipsoriatic therapies. The treatment strategy in patients with severe psoriasis may have an impact on cardiovascular outcomes and randomized trials to evaluate the cardiovascular safety and efficacy of systemic antipsoriatic therapies are called for.
PubMed ID
25303139 View in PubMed
Less detail

[Development in mortality, incidence and lethality of ischemic heart disease in Denmark 1982-1992]

https://arctichealth.org/en/permalink/ahliterature54470
Source
Ugeskr Laeger. 1997 Sep 8;159(37):5508-13
Publication Type
Article
Date
Sep-8-1997
Author
M. Osler
T I Sørensen
S. Sørensen
K. Rostgaard
G B Jensen
L. Iversen
T S Kristensen
M. Madsen
Author Affiliation
Københavns Universitet, Afdeling for Social Medicin og Psykosocial Sundhed.
Source
Ugeskr Laeger. 1997 Sep 8;159(37):5508-13
Date
Sep-8-1997
Language
Danish
Publication Type
Article
Keywords
Adult
Aged
Denmark - epidemiology
English Abstract
Female
Humans
Incidence
Male
Middle Aged
Myocardial Infarction - epidemiology - mortality
Myocardial Ischemia - epidemiology - mortality
Registries
Abstract
In Denmark, as in many other Western countries, a decline in mortality from ischaemic heart disease (IHD) has been observed. The present study assesses whether the decline in IHD mortality is due to a decrease in incidence and/or case-fatality, and whether parallel changes occurred in the various manifestations of IHD requiring hospitalization. The National Patient Register of hospital discharges and the Causes-of-Death Register were linked and all cases of first admission for IHD including acute myocardial infarction (AMI) and fatal first manifestation of IHD since 1977 in the entire Danish population were identified. Cases of AMI and IHD were considered as incident cases if no admission for these diagnoses had occurred during the preceding five years for the same person. Sex-specific, age-standardized annual mortality, incidence and case-fatality rates of AMI (ICD8 code 410), narrowly defined IHD (NIHD, ICD8 codes 410-4) and broadly defined IHD (BIHD, ICD8 codes 410-4, 427 & 795-6) were calculated for the period 1982 through 1992. During the entire period the age-standardized mortality of AMI, NIHD and BIHD decreased in both men and women. The incidence of AMI and NIHD decreased, while the incidence of BIHD remained constant. Case-fatality of AMI decreased in both men and women, while case-fatality of NIHD and BIHD decreased in men and in women aged 0-64 years only. The declining mortality from IHD in Denmark may be partly due to declining incidence as well as declining case-fatality, but changes in disease manifestation or a diagnostic drift may also contribute, since more broadly defined diagnostic groups showed less or no decline in incidence.
PubMed ID
9312919 View in PubMed
Less detail

38 records – page 1 of 4.